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Summary. Our clinical and experimental studies have so 
far demonstrated, that the drugs used in anaesthesia; such 
as hypnotics, sedatives, narcotics or muscle relaxants, 
release histamine. 
The intravenous hort acting anaesthetic etomidat has 
not shown either in experimental studies or in clinical use 
for 10 years any anaphylactoid reaction. The benzodiaze- 
pines are another group of drugs which appear not to 
release high amounts of histamine. 
Accurate studies on volunteers as well as on patients 
on the application of H 1- and H2-receptor antagonists have 
demonstrated an effective inhibition of the anaphylactoid 
reaction. We suggest hat in case of a history of allergy 
H 1- and Hz-receptor antagonists hould be administered 
as a prophylactic premedication. 
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Histamin-Freisetzung in der An~isthesie und Chirurgie. 
Pr~imedikation mit H,- und Hz-Rezeptor-Antagonisten: 
Indikationen, Vorteile und mfgliche Probleme 
Zusammenfassung. Die in der Anaesthesie verwendeten i.v. 
Hypnotika, Anaesthetika und Muskelrelaxantien sind in 
der Lage Histamin freizusetzen. Dies ist das Ergebnis einer 
12jfihrigen klinisch-experimentellen Forschung. 
Das i.v. zu applizierende Hypnotikum Etomidat hat so- 
wohl im Experiment als auch nach 10j~ihriger klinischer 
Erfahrung noch keine anaphylaktoide R aktion verursacht. 
Aber auch die Benzodiazepine sind keine potenten Hista- 
minfreisetzer. 
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Die Applikation von H 1- und H2-Rezeptor-Antagoni- 
sten erscheint nach sorgf/iltiger Prtifung sowoht im kli- 
nischen Experiment als auch in der Klinik in der Lage zu 
sein, anaphylaktoide Reaktionen zu verhindern. Es wird 
daher bei entsprechender Anamnese ine prophylaktische 
Praemedikation mit H1- und H2-Rezeptor-Antagonisten 
empfohlen. 
Sehliisselw~irter: Histamin-Ereisetzung - An/isthesie Chir- 
urgie Antihistaminika 
1 Modem Anaesthesia and Histamine Release in Man 
Although modern anaesthesia using combined narcotics 
offers a pleasant, mentally less disturbing, experience at 
operation for the patient, it also involves dangers. Cardio- 
vascular disturbances (apart from unexpected side-effects) 
mostly during induction, have been recognized more and 
more in recent years [2, 9, 11, 12]. 
The identification of certain symptoms due to histamine 
is very important for the anaesthesist. 
1.1 Evidence for  Histamine Release in Man 
as an Important Pathophysiotogieal Event 
Histamine release in man following i.v. injection of anaes- 
thetic and hypnotic agents under clinical conditions was 
first demonstrated in 1969 in volunteers and patients uffer- 
ing from severe reactions to the anaesthetic druc propanidid 
(Epontol) [6, 17]. 
In all I0 volunteers of one experimental series an in- 
crease of plasma histamine levels up to 3 ng/ml was deter- 
mined (Fig. 1). In 3 other volunteers and in 1 patient with 
high basal histamine very high plasma levels were observed 
(Fig. 2) (patient Gr. AL, No. 1). The kinetics of the plasma 
histamine levels in all cases corresponded largely to a 
Bateman function which should be expected in the case 
of histamine release [9, 14]. 
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Fig. 1. P lasma histamine concentrat ions in human subjects after 
intravenous injection of propanidid (Epontol).  Mean values 4-SEM 
from 12 patients [•9] 
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Fig. 2. Correlat ion between plasma histamine concentrat ion,  pulse 
rate and blood pressure in 4 cases of  pseudo-allergic reactions to 
propanidid (Epontol).  Values from single determinat ions [19]. 
= Histamine;  - -  = pulse rate; --[-i- = blood pressure; n.p. = not 
palpable;  n.m. = not  measurable 
Changes in plasma histamine levels after injection of 
propanidid were accompanied by clinical symptoms and 
biological reactions which in intensity and time course cor- 
responded to the alterations in plasma histamine concentra- 
tion (Fig. 3). 
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Fig. 3. Histamine concentrat ion i p lasma and whole blood, gastric 
acid secretion, blood pressure and heart rate after intravenous in- 
jection of propanidid (Epontol). Mean vatues±SEM from 5 pa- 
tients. - -  = Heart  rate; . . . .  blood pressure [19] 
Since our first investigation in 1969 [17] we investigated 
eight anaesthetic and hypnotic agents in man. Our studies 
on thiopentone in volunteers were made in 1970 (Fig. 4), 
on methohexitone in 1971, for propanidid, althesin and eto- 
midat a controlled double cross-over andomized study 
(propanidid versus etomidat) was performed in 1972 [19, 
20] flunitrazepam (Rohypnol, Roche) was tested in 1976 
and diazepam and lormetazepam together with etomidat 
in 1977 [611]. In 1979, we finished the study investigating 
the protective ffect of H 1- and H2-receptor antagonists 
with propanidid [4, 14, 15]. 
Following flunitrazepam 50% of the test subjects 
showed elevated plasma histamine levels, but after etomidat 
there was no increase in the plasma histamine concentration 
during the time of investigation i any of the 9 volunteers. 
Thus, etomidat was the only intravenous hypnotic drug 
which did not cause histamine release in these xperiments 
[8, 9]. 
The changes in heart rate and blood pressure after injec- 
tion of the anaesthetics have already been reported in other 
publications for all the drugs. The stimulation of gastric 
acid secretion (Figs. 3, 4) [19] has been tested after propani- 
did and thiopentone. From their limited histamine release, 
it would not be expected that any of the drugs tudied 
will normally cause serious circulatory disturbances follow- 
ing their administration. Using flunitrazepam there was no 
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Fig. 4. Histamine concentration in whole blood and plasma, baso- 
phils, gastric acid secretion, bl od pressure and heart rate after 
intravenous injection of thiopentone. Mean values with SEM. 5 
subjects were tested after the injection of thiopentone 5 mg/kg, 
injection time 20 sec. All parameters were studied simultaneously 
in each person. Values at zero time for heart rate (---) and blood 
pressure (----) 
change in blood pressure in any of the volunteers within 
the whole period of investigation. However, two of the vol- 
unteers howed a slight tachycardia (increase in heart rate, 
17 and 20 bpm) starting 1 min after drug injection and 
lasting for 10 rain in both cases. These two individuals 
showed the highest plasma histamine levels after flunitraze- 
pam injection. 
Administration of diazepam cannot be claimed to liber- 
ate histamine despite a slight increase in the plasma hista- 
mine value from 0.35 to 0.6 ng/ml on average, since in no 
circumstance was 1 ng/ml attained. We have demonstrated 
[15] that 1 ng/ml is the cut-off point between pathological 
and physiological plasma histamine levels. 
1.2 Histamine Release in Man Following 
Intravenous Injection of Muscle Relaxants 
in Combination with Etomidat 
The muscle relaxants (suxamethonium, pancuronium and 
alloferin) [11, 15] have been investigated for their hista- 
mine-releasing activity in man. Using the experimental de- 
sign described in previous communications [9, 13, 19, 25], 
a combination of drugs was administered to each of the 
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test individuals, since for clinical and ethical reasons it was 
impossible to administer muscle relaxants to human sub- 
jects without also administering atropine and hynotics. 
All three muscle relaxants released histamine. The high- 
est incidence was found following suxamethonium, the low- 
est after pancuronium. Prostigmine was without effect in 
this series of 15 individuals. The combination of the differ- 
ent drugs apparently had little effect on histamine release 
since etomidat injected repeatedly did not alter plasma his- 
tamine levels and did not change them when given alone. 
Furthermore, the kinetics of histamine release after injec- 
tion of the muscle relaxants corresponded well with those 
which were expected for a histamine release when given 
alone, especially regarding the time of onset and the velocity 
of increase of the elevated plasma histamine levels. But clin- 
ical observations (occurrence of erythema etc.) strongly 
suggest that there may be a slight histamine releasing effect 
of etomidat when administered repeatedly during the time 
of muscle relaxation [5, 15]. 
Clinical symptoms of pseudo-allergic reactions were ob- 
served in many subjects during the whole series of experi- 
ments. Tachycardia occurred in all subjects receiving etomi- 
dat and pancuronium and in most of the individuals being 
treated with etomidat and alloferin. The skin reactions cor- 
responded partly with the occurrence of elevated plasma 
histamine concentrations. But 2 persons with increased 
plasma histamine levels after injection of suxamethonium 
and 1 person after alloferin did not show any skin reaction. 
Local histamine r lease may cause single wheals but hista- 
mine may be diluted during diffusion into the vessels to 
such an extent hat it does not significantly increase plasma 
histamine levels and does not produce the systemic effects 
of a pseudo-allergic reaction. 
A certain combination of drugs used for muscle relaxa- 
tion under clinical conditions releases histamine in man and 
the muscle relaxants are themselves mainly responsible for 
this. Before the investigation presented here, no histamine 
release or pseudo-allergic reactions after etomidat had been 
Table 1. Plasma histamine values in healthy subjects aft r intrave- 
nous injections oflormetazepam 
Test Plasma histamine value, 
subject ng/ml 
No. 
before after a
Responsive subjects 
t 0.35 2.7 (5) 
2 0.4 2.05 (5) 
3 0.75 1.15 (5) 
Mean 0.50 2.00 
Non-responsive subjects 
1 0.1 0.a (1) 
2 0.5 0.8 (5) 
3 0.15 0.3 (5) 
4 0.45 0.4 (1) 
5 0.75 0.95 (10) 
6 0.5 0.4 (1) 
7 0.65 0.9 (5) 
Mean 0.45 +_ 0.25 0.55_+ 0.35 
" Highest value measured; time (min) in parentheses 
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Table 2. Comparison of 2 clinically symptomless subjects who showed an increase in plasma histamine value after 
lormetazepam and etomidat 
Subject Pharma- Plasma histamine Notes Etomidat Notes 
No. cological value, ng/ml 
data 
before after before after 
1. K.H. diazepam 0.2 0.4 (5) - 0.25 0.45 (1) 
12.12.77 
3. S.H.  diazepam 0.5 0.75 (5) 0.4 0.7 (1) 
12,12.77 
t.K.H, lormetazepam 0.35 2.7 (5) HFconst. 0.55 3.2 (5) 
15. t2.77 AP const. 
3. S.H. lormetazepam 0.4 2.05 (5) HF const. 0.35 1.85 (5) 
16.12.77 AP const. 
thrombosis 
myoclonus 
HF const. 
AP const. 
° goose pimples' 
HF const. 
AP const. 
'pins and needles' 
HF = heart rate, AP= arterial blood pressure. Fo  further conditions see Table 1 
recognized [9]. On the other hand, in some subjects we 
found elevated plasma histamine values after giving alto- 
ferin, pancuronium and suxamethonium with etomidat. In 
these subjects, clinical symptoms (erythema) were noted 
which at the second injection at least indicated a local hista- 
mine liberation [11, 15]. 
1.3 Histamine Release After Combination of two Hypnotics 
In recent years it has become apparent hat some drugs 
after some time develop increasing incompatibility [11, 17, 
19]. Thus, in the case of etomidat, and particularly in com- 
bination with a further drug, the possibility of a release 
of histamine cannot be excluded. Two instances of hista- 
mine release were observed, but which drug in the combina- 
tion or whether the combination itself releases histamie is 
difficult to decide [11]. 
In contrast o diazepam, lormetazepam in 2 subjects 
showed a significant release of histamine (Table 1). 
In the 2 responsive subjects, who earlier had increases 
in histamine after lormetazepam, a subsequent etomidat 
injection again caused a further histamine release. Since 
an elimination kinetic for histamine was evident both before 
etomidat and also after injection of this short-acting hyp- 
notic, this histamine release was unequivocably shown. 
Since the 10 subjects received two hypnotics - i.e. etomi- 
dat and lormetazepam within a few days (Table 2) both 
responsive subjects, No. 1 and 3, according to the chrono- 
logical order of the hypnotics are specified separately. In 
both instances diazepam/etomidat was given first, and 3 
to 4 days later the combination lormetazepam/etomidat. 
At the elevated histamine concentration of 2.7 ng/ml 
after lormetazepam and 3.2 ng/ml after etomidat in subject 
No. 1 (K.H.), cardio-circulatory disturbances were expected 
but an increased heart rate did not occur. The mean arterial 
pressure after diazepam decreased in the first 5 to 10 min 
while the heart rate remained constant, whereas after lorme- 
tazepam no changes occurred. Since no cardiovascular side 
effects occurred with the combination lormetazepam/etomi- 
dat at a plasma histamine value of 2.7 to 3.2 ng/ml, lormeta- 
zepam may also have acted as an antihistaminic. Based 
on in vitro and in vivo findings from animal experiments 
using the guinea-pig asthma model, it can be claimed that 
lormetazepam and lorazepam have histamine antagonistic 
effects (H~-type). So far in the clinic, no pseudo-allergic 
side-effects have been ascertained in about 1,200 lormetaze- 
pam administrations, nor after repeated injections of up 
to 80 mg over several days. 
Watkins [26] also suggested the possibility of histamine 
release after etomidat, but in such small amounts that it 
disappears from the circulation as fast as it is liberated, 
so that a circulatory reaction does not occur. Subclinical 
reactions after etomidat such as chemotaxis of blood leuco- 
cytes through the surrounding tissue were observed. This 
is probably due to the production of anaphylatoxins after 
C3 and C5 activation, which was measured by the decrease 
of complement factors and immunoelectrophoresis. 60% 
of all patients treated with propanidid, althesin, methohexi- 
tone [27] or etomidat showed this effect. Whereas the pro- 
duction of anaphylatoxins reached its highest value only 
30 to 40 min after the administration of etomidat, they ap- 
peared after the other drugs as early as 5 min after injection. 
2 Prophylaxis of Anaphylactoid Reactions i  Man 
by Hi-Receptor Antagonists and Glucocorticoids 
15 years ago we started systematically premedication with 
antihistaminics for every anaesthesic performed with pro- 
panidid. 
In a retrospective study of the cases in whom we used 
Hi-receptor antagonists for premedication, we could not 
see a decrease in either frequency or potency of the anaphy- 
lactoid reactions due to propanidid. 
In the retrospective evaluation of 1,700 anaesthesia with 
an Hi-receptor antagonist (clemastine) as premedication 29
allergic reactions were seen [3]. 10 patients howed a severe 
reaction with decrease in blood pressure. 
A very important example, the fact that premedication 
with HI-receptor antagonist does not help was the case 
of the patient G.R., 1969, who sulffered cardiac arrest be- 
cause of a histamine release up to 100 ng/ml plasma [19]. 
The administration of clemastine was unable to prevent 
the reaction to such a massive release of histamine. Pred- 
nisolone had been found very effective during a previous 
incident in this patient. We discussed this problem with 
him. The patient consented to an ther propanidid anaesthe- 
sia after premedication with high doses of prednisolone and 
using a reduced dose of propanidid. About two months 
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No. of subject 
18 
11 
30 
Plasma histamine levels 
[ng/ml] 
Sodium + propanidid 
1,7 ng/ml 
1,8 ng/ml 
H~ + H 2 + propanidid 
1,7 ng/ml 
Sodium + propanidid 
1,6 ng/ml 
Symptoms 
Flush, Headache 
Flush, HF 
Pharyngeal 
narrowness 
HF unchanged 
Fig. 5. Premedication with H 1- and H2-receptor-antagonists before Propanidid anaesthesia 
HF = heart rate, sodium = NaC1 
later a further operation was necessary. As premedication, 
prednisolone (2 mg/kg) together with clemastine was in- 
jected intravenously. After hat propanidid anaesthesia pro- 
ceeded without any complication. Later on, two more oper- 
ations were necessary. We premedicated always with clema- 
tine and prednisolone. No complication was observed dur- 
ing and after the anaesthesia. The plasma histamine concen- 
tration before the premedication was 9.3 ng/ml. It increased 
to 16.5 ng/ml 1 min after propanidid, to 30 ng/ml 5 rain 
after injection and to 45 ng/ml at 10 and 15 rain after injec- 
tion [19]. 
3 The Introduction of Hz-Receptor Antagonists: 
The H1- and H2-Bloekade as Premedieation 
in Anaesthesia and Surgery 
Although a glucocorticoid has shown this positive function 
first [7, 19] Lorenz recommended in 1973 in London (H 2- 
Meeting) as an ideal premedication a combination of H1- 
and Hz-receptor antagonists in order to block the histamine 
release effect after infusion of plasma substitutes. With the 
successful synthesis of a specific H2-receptor antagonist by 
Black et al. [1] new possibilities for the investigation of 
the role of histamine during anaphylactoid reactions were 
introduced. 
The best technique for demonstrating free histamine in 
adverse responses to intravenous agents is when a random- 
ized controlled clinical trial is performed in which con- 
committantly altered histamine contents are measured, and 
histamine induced biological reactions as well as clinical 
symptoms are recorded and these reactions are prevented 
in a treatment group by application of H1- and Hz-receptor 
antagonists. 
In this way we studied, from 1977, adverse reactions 
to the plasma substitute Haemaccel in two groups, 25 hu- 
man volunteers, each, in which saline or the combination 
of an H~- and H2-blocker was given [16]. 
Elevated plasma histamine levels were shown in both 
groups of test persons with a high incidence. 
Clinical symptoms and biological reactions correspond- 
ing quantitatively to the histamine levels were observed only 
in the control group, not in the subjects being treated by 
the H 1- and Hz-blocker. 
Especially interesting was that there was no increase 
in heart rate in the treatment group, whereas the histamine 
plasma levels were significantly increased [16]. 
In a controlled randomized single-blind trial in 32 vo- 
lunteers it was determined whether an i.v. premedication 
(consisting of dimethpyrindene 0.1 mg/kg and cimetidine 
5 mg/kg i.v.) prevented the effects of histamine release after 
administration of propanidid. The study was designed as 
cross-over versus NaC1. The HI-blocking dimethpyrindene 
was injected within 30 s, the H2-receptor antagonist cimeti- 
dine consecutively within 2 min [4, 24]. 
Elevated plasma histamine levels were shown in both 
groups. But their extent was relatively small. It was, how- 
ever, interesting to note, that the "propanidid flush" was 
to a large extent prevented in the H 1- and Hz-group, and 
the headache - resembling "a  hangover" - was more fre- 
quently observed in the saline group than in the treatment 
group. Myoclonia, however, occurred more in the treated 
group than in the control group. Except for preventing a
flush however, these differences, were not significant in the 
small sample of 32 subjects. 
The considerable increase in heart rate in the first 
minute after propanidid was also significantly reduced by 
premedication with H1- and H2-blockers, whereas the hy- 
potensive response remained the same in the two groups. 
The influence of the H 1- and Hz-blockers on the propani- 
did-induced tachycardia is a remarkable finding since at 
this time the plasma histamine levels have still not reached 
the highest value. Like wheals in the skin this may be 
another example the fact that local histamine release is not 
or not yet associated with an increase in plasma histamine 
levels and therefore not or not yet with a systemic reaction 
to the histamine release. 
Some interesting aspects from this cross-over study 
should be taken into account. Histamine release in the sec- 
ond injection of propanidid is less pronounced than in the 
first injection. It is important that after the second injection 
of propanidid a great number of volunteers did not show 
a significant increase of histamine plasma levels. It is sug- 
gested that this phaenomenon is due to tachyphylaxis. 
The symptoms following the increase of histamine plas- 
ma levels are demonstrated in Fig. 5. Volunteer No. 18: 
flush, headache; No. 11: flush, increase of heart rate of 
54 bpm. In Case of volunteer No. 30 the histamine plasma 
levels were increased but neither tachyphylaxis nor head- 
ache was found. As we demonstrated ven when an increase 
of histamine plasma levels up to 1.7 ng/ml was measured, 
no anaphylactoid symptoms were found. From this we con- 
clude that the combination of H~- and Hz-receptor antago- 
nist for premedication significantly decreases the incidence 
of side effects. 
In general the side effects of the premedieation with 
a combination of H1- and H2-receptor antagonists may 
be considered as weak, and it seems that they depend 
mainly on the speed of injection. The administration of 
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dimethpyrindene and cimetidine in less than one minute 
causes more often side effects whereas the stow injection 
of  dimethpyridene (2min) and cimetidine (2 min) did not 
cause any side effect in 300 orthopaedic patients [21, 23, 
24]. 
4 Considerations About the Premedieation 
with H1- and H2-BIockers: Alternatives, Questions 
to be Solved and Possible Indications 
4.1. Considerations 
- In every evaluation of  a newly synthetized rug the ques- 
tion whether the drug releases histamine should be ans- 
wered. 
- The pharmaceutical companies should produce drugs 
which do not release histamine. So we accepted in 1972 
with pleasure the development of  etomidat, a barbiturate 
free hypnotic, because propanidid would no longer be re- 
quired [3, 9]. 
We accepted it in spite of  disadvantages such as myo- 
clonia and vein pain. 
We considered as a great advantage that the drug did 
not release histamine [9]. 
- I f  one substance does release histamine the producer 
should try to improve the drug; for example, the classical 
Haemaccel was replaced as plasma substitutes by the puri- 
fied Haemaccel [18, 22]. 
- Drugs which release histamine should be injected slowly 
[20] 
- In certain situations we should replace some drugs with 
others in order to avoid some hazards; for instance in long 
lasting operations we should use pancuronium instead of 
suxamathonium. 
- In high risk patients we should take a good case history 
to determine the likelihood of allergy. 
4.2 Alternatives 
In several experiences ( ince 1969) we noticed that applica- 
tion of glucocorticoids 10 minutes before the start of  anaes- 
thesia completely inhibited the incidence of allergic reac- 
tions. This would allow us to consider glucocorticoids as 
an alternative way of premedication in allergic patients, 
taking in account he side effect of the drug. 
4.3 Questions to be Clarified 
- It is planned to determine if premedication with H 1- and 
Hz-receptor antagonists is ideal by testing the drugs in 5 
to 10 anaesthesia departments with a prospective controlled 
study and to clarify which reactions are caused by histamine 
release during different kinds of  operations 
- Do anxious patients have a higher incidence of anaphy- 
lactoid reactions? 
-Do  poor-risk patients (polytrauma, septicaemia, etc.) 
have a higher incidence of these reactions? 
4.4 Indications for the Use of H 1- 
and H2-Receptor Antagonists for Premedication 
- Hypersensitivity reactions during previous anaesthesia or 
during in previous administration of  substances used in X- 
ray procedure or after plasma substitutes. 
- Second drug exposure within few days (Watkins theory 
of  short-term-memory-effect). 
- Clear-cut history of allergy, such as asthma, hay-fever. 
- Expectation of a heavy blood loss because it is possible 
that during transfusion exogenous histamine will be intro- 
duced into the patient. 
- Use of  pallacos in patients with an allergic history and 
cardiac insuffiency 
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